UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Noncontrolling Interest	Parent
Beginning balance (in shares) at Dec. 31, 2022				43,743,174	97,843,570
Beginning balance at Dec. 31, 2022				$ 0	$ 1	$ 274,057	$ (1,206)	$ (72,948)		$ 199,904
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B Common Stock to Class A Common Stock (in shares)				74,239,844	74,239,844
Conversion of Class B Common Stock to Class A Common Stock				$ 1	$ (1)					0
Issuance of common stock upon exercise of stock options (in shares)				88,957
Issuance of common stock upon exercise of stock options						67				67
Issuance of common stock in connection with employee stock purchase plan (in shares)				38,879
Issuance of common stock in connection with employee stock purchase plan						264				264
Issuance of common stock upon vesting of restricted stock units (in shares)				71,557
Stock-based compensation expense						2,796				2,796
Cumulative translation adjustment	$ 365						365			365
Unrealized loss on investments	(83)						(83)			(83)
Net income (loss)	(9,860)							(9,860)		(9,860)
Net loss attributable to noncontrolling interest	0
Ending balance (in shares) at Mar. 31, 2023				118,182,411	23,603,726
Ending balance at Mar. 31, 2023				$ 1	$ 0	277,184	(924)	(82,808)		193,453
Beginning balance (in shares) at Dec. 31, 2023		120,629,000	23,482,000	120,629,147	23,482,057
Beginning balance at Dec. 31, 2023	$ 224,315			$ 1	$ 0	291,898	(752)	(71,998)	$ 5,166	219,149
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	469,879			469,879
Issuance of common stock upon exercise of stock options	$ 844					844				844
Issuance of common stock upon vesting of restricted stock units (in shares)				145,844
Stock-based compensation expense	5,115					5,115				5,115
Cumulative translation adjustment	(485)						(485)			(485)
Unrealized loss on investments	(744)						(744)			(744)
Net income (loss)	2,138							2,138		2,138
Net loss attributable to noncontrolling interest	(135)								(135)
Ending balance (in shares) at Mar. 31, 2024		121,245,000	23,482,000	121,244,870	23,482,057
Ending balance at Mar. 31, 2024	$ 231,048			$ 1	$ 0	$ 297,857	$ (1,981)	$ (69,860)	$ 5,031	$ 226,017